Use of patch testing for the diagnosis of abacavir-related hypersensitivity reaction in HIV patients

Dermatologic Therapy

Volumn 24, Issue 6, 2011, Pages 591-594

  Giorgini, S ^a   Martinelli, C ^a   Tognetti, L ^a   Carocci, A ^a   Giuntini, R ^a   Mastronardi, V ^a   Torricelli, F ^b   Leoncini, F ^a   Lotti, T ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

abacavir hypersensitivity; adverse effects; patch test; pharmacogenetic test; positive predictive value

Indexed keywords

ABACAVIR; HLA ANTIGEN; HLA B5701 ANTIGEN; PETROLATUM; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE DURATION; DRUG HYPERSENSITIVITY; FEMALE; GENETIC MARKER; GENETIC SCREENING; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PATCH TEST; PHARMACOGENETICS;

ADULT; AGED; AGED, 80 AND OVER; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOPSY; DIDEOXYNUCLEOSIDES; DRUG HYPERSENSITIVITY; FEMALE; GENETIC MARKERS; HIV INFECTIONS; HLA-B ANTIGENS; HUMANS; ITALY; MALE; MIDDLE AGED; PATCH TESTS; PREDICTIVE VALUE OF TESTS; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 84860134938     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2012.01409.x     Document Type: Article

References (10)

1. Fox J, Boffito M, Wiston A,. The clinical implications of antiretroviral pharmacogenomics. Pharmacogenomics 2006: 7 (4): 587-596. (Pubitemid 43891415)
2. Carr A, Cooper DA,. Adverse effects of antiretroviral therapy. Lancet 2000: 356: 1423-1430.
3. Phillips E, Malall S,. Drug hypersensitivity in HIV. Curr Opin Allergy Clin Immunol 2007: 7 (4): 324-330. (Pubitemid 47052020)
4. Wolkenstein P, Chosidow O, Flechet ML, et al,. Patch testing in severe cutaneous adverse drug reactions, including Steven-Johnson syndrome and toxic epidermal necrolysis. Contact Dermatitis 1996: 35: 234-236. (Pubitemid 26408155)
5. Phillips E, Gavin W, Rupert K, et al,. Clinical and immunogenetic correlates of abacavir hypersensitivity. AIDS 2005: 19 (9): 979-981. (Pubitemid 40834943)
6. King D, Tomkins S, Waters A, et al,. Intracellular cytokines may model immunoregulation of abacavir hypersensitivity in HIV-infected subjects. J Allergy Clin Immunol 2005: 115: 1081-1087. (Pubitemid 40616227)
7. Phillips EJ, Sullivan IR, Knowles SE, et al,. Utility of patch testing in patients with hypersensitivity syndromes associated with abacavir. AIDS 2002: 15: 2223-2225. (Pubitemid 35387279)
8. Martinelli C, Giuntini R, Landonio S, et al,. Utility of patch testing in HIV patients with cutaneous adverse reaction to highly active antiretroviral therapy. J Eur Acad Dermatol Venereol 2004: 18 (Suppl. 2): 107.
9. Barbaud A, Goncalo M, Bruynzeel D, et al,. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse reactions. Contact Dermatitis 2001: 45: 321-328. (Pubitemid 34056345)
10. Mallal S, Nolan D, Witt C, et al,. Association between presence of HLA-B 5701,HLA-DR7,and HLA-DQ3 and Hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet 2002: 359: 727-732. (Pubitemid 34215071)